This statistic depicts the estimated size of the anti-cancer drug market in South Korea from 2014 to 2020. In 2020, the anti-cancer drug market in South Korea is forecasted to be worth approximately 2.42 trillion South Korean won.
Estimated size of the anti-cancer drugs market in South Korea from 2014 to 2020 (in trillion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Anti-diabetics estimated market size in South Korea 2014-2020
- Premium Statistic Cardiovascular disease drugs estimated market size in South Korea 2014-2020
- Premium Statistic Cholesterol drugs estimated market size in South Korea 2014-2020
- Premium Statistic Price increase select geriatric drugs in the U.S. in 2020
- Basic Statistic Price increase of brand drugs mostly used by US seniors by use and competition 2020
- Premium Statistic Osteoporosis drug market size in China 2008-2016
- Premium Statistic Calcitriol market size in China 2007-2016
- Premium Statistic Market share of anti-osteoporosis drugs in public medical institutions China 2016
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2022
- Basic Statistic Revenue of Alliance Pharma product brands 2022
About the region
10
- Premium Statistic Most common prescription drugs for prostatic hyperplasia South Korea 2016
- Premium Statistic BPH outpatient prescription medicine sales in South Korea 2016, by age group
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic Distribution of incrementally modified drugs approved South Korea 2009-2016, by type
- Premium Statistic Interior & remodeling market size in South Korea 2000-2020
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
Selected statistics
6
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Basic Statistic Pharma company ranking by governance of access in developing countries 2022
- Basic Statistic Retail price increase of geriatric drugs in the U.S. in 2020, by manufacturer
- Basic Statistic Level 1 ATC therapy classes by share of total public drug costs in Canada 2021/2022
- Basic Statistic Dispensed mineral supplements in the Netherlands 2014-2022
- Basic Statistic Sales of the most used reimbursed drugs in Norway 2020
- Basic Statistic Value share of generic pharmaceuticals market in Czechia 2011-2021
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Premium Statistic Prescription drug purchase growth SEA 2019-2020 by type
- Premium Statistic Self-medication market sales in Europe in 2020, by country
- Premium Statistic Sales of pharmaceutical drugs Thailand 2021, by type
Related statistics
10
- Premium Statistic Biopharmaceutical market size in South Korea 2012-2022
- Premium Statistic Herbal raw material market size in South Korea 2012-2022
- Premium Statistic Changes in outpatient prescriptions in Busan and Gyeongnam South Korea 2020
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Premium Statistic Drugs for Alzheimer's disease sales in South Korea 2011-2016
- Premium Statistic Ultrasound bone densitometer market size in South Korea 2010-2015
- Premium Statistic South Korea's diabetes therapy and drug delivery market size 2014-2023
- Premium Statistic Leading pharmaceutical businesses South Korea 2022, by revenue
- Premium Statistic Traditional medicine industry sales in South Korea 2021, by sector
Further related statistics
9
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Leading European medtech countries based on market capitalization 2014
- Global pharmaceutical pipeline by therapy area 2013-2017
- Leading banks in the Middle East in 2023, by brand value
- MorphoSys' research & development expenditure 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Leading European medtech countries based on market capitalization 2014
- Global pharmaceutical pipeline by therapy area 2013-2017
- Leading banks in the Middle East in 2023, by brand value
- MorphoSys' research & development expenditure 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
COMPA. (March 31, 2015). Estimated size of the anti-cancer drugs market in South Korea from 2014 to 2020 (in trillion South Korean won) [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/777776/south-korea-anti-cancer-drugs-estimated-market-size/
COMPA. "Estimated size of the anti-cancer drugs market in South Korea from 2014 to 2020 (in trillion South Korean won)." Chart. March 31, 2015. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/777776/south-korea-anti-cancer-drugs-estimated-market-size/
COMPA. (2015). Estimated size of the anti-cancer drugs market in South Korea from 2014 to 2020 (in trillion South Korean won). Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/777776/south-korea-anti-cancer-drugs-estimated-market-size/
COMPA. "Estimated Size of The Anti-cancer Drugs Market in South Korea from 2014 to 2020 (in Trillion South Korean Won)." Statista, Statista Inc., 31 Mar 2015, https://www.statista.com/statistics/777776/south-korea-anti-cancer-drugs-estimated-market-size/
COMPA, Estimated size of the anti-cancer drugs market in South Korea from 2014 to 2020 (in trillion South Korean won) Statista, https://www.statista.com/statistics/777776/south-korea-anti-cancer-drugs-estimated-market-size/ (last visited March 29, 2024)
Estimated size of the anti-cancer drugs market in South Korea from 2014 to 2020 (in trillion South Korean won) [Graph], COMPA, March 31, 2015. [Online]. Available: https://www.statista.com/statistics/777776/south-korea-anti-cancer-drugs-estimated-market-size/